CAPRICOR THERAPEUTICS INC (CAPR) Stock Earnings & Estimates
NASDAQ:CAPR - US14070B3096 - Common Stock
6.28 USD
+0.02 (+0.32%)
6.31 USD
+0.03 (+0.48%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.55M 962.50% | 25.178M 887.38% | 22.271M -11.55% | 1.349M -93.94% | 83.119M 6,061.53% | 110.54M 32.99% | 159.13M 43.96% | 287.91M 80.93% | 390.25M 35.55% | 559.71M 43.42% | 686.19M 22.60% | |
| EBITDA YoY % growth | -21.7M -39.19% | -4.341M 80.00% | -18.09M -316.73% | -103.122M -470.04% | -1.224M 98.81% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -22.23M -40.34% | -5.41M 75.66% | -19.516M -260.74% | -101.879M -422.04% | -28.438M 72.09% | -19.257M 32.28% | 48.801M 353.42% | 158.82M 225.44% | 222.91M 40.35% | 331.97M 48.93% | 430.16M 29.58% | |
| Operating Margin | -871.76% | -21.49% | -87.63% | -7,552.21% | -34.21% | -17.42% | 30.67% | 55.16% | 57.12% | 59.31% | 62.69% | |
| EPS YoY % growth | N/A -41.28% | -0.87 29.22% | -1.20 -37.93% | -2.18 -81.69% | -1.34 38.48% | -0.41 69.58% | 0.63 253.75% | 1.63 159.35% | 3.12 91.85% | 2.89 -7.52% | 4.00 38.52% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.56 -46.96% | -0.54 -239.47% | -0.50 5.70% | -0.50 13.03% | 0.24 142.37% | 0.18 133.80% |
| Revenue Q2Q % growth | 543.997K -75.95% | 816K -92.67% | 48.96M | 612K | 52.696M 9,586.83% | 69.875M 8,463.11% |
| EBITDA Q2Q % growth | -27.336M -128.55% | -27.03M -330.92% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -24.451M -87.94% | -23.803M -209.22% | -22.512M 9.89% | -22.998M 17.03% | 32.456M 232.74% | -25.683M -7.90% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.57 -62.86% | -0.48 | -0.09 | -19.18% |
| Q1 2025 Q2Q % growth | -0.53 -70.97% | -0.32 | -0.21 | -64.08% |
| Q4 2024 Q2Q % growth | -0.16 -700.00% | -0.27 | 0.11 | 40.43% |
| Q3 2024 Q2Q % growth | -0.38 -52.00% | -0.37 | -0.01 | -3.97% |
| Q2 2024 Q2Q % growth | -0.35 -20.69% | -0.36 | 0.01 | 3.61% |
| Q1 2024 Q2Q % growth | -0.31 | -0.12 | -0.19 | -168.17% |
| Q4 2023 Q2Q % growth | -0.02 93.55% | -0.09 | 0.07 | 78.21% |
| Q3 2023 Q2Q % growth | -0.25 3.85% | -0.30 | 0.05 | 15.48% |
| Q2 2023 Q2Q % growth | -0.29 | -0.36 | 0.07 | 18.77% |
| Q1 2023 Q2Q % growth | -0.31 3.13% | -0.33 | 0.02 | 5.02% |
| Q4 2022 Q2Q % growth | -0.31 -19.23% | -0.34 | 0.03 | 9.28% |
| Q3 2022 Q2Q % growth | -0.26 -52.94% | -0.30 | 0.04 | 13.10% |
| Q2 2022 Q2Q % growth | -0.29 -38.10% | -0.26 | -0.03 | -11.50% |
| Q1 2022 Q2Q % growth | -0.32 -39.13% | % | ||
| Q4 2021 Q2Q % growth | -0.26 -23.81% | -0.19 | -0.07 | -34.16% |
| Q3 2021 Q2Q % growth | -0.17 15.00% | -0.22 | 0.05 | 24.24% |
| Q2 2021 Q2Q % growth | -0.21 8.70% | -0.23 | 0.02 | 10.49% |
| Q1 2021 Q2Q % growth | -0.23 23.33% | % | ||
| Q4 2020 Q2Q % growth | -0.21 38.24% | -0.20 | -0.01 | -2.94% |
| Q3 2020 Q2Q % growth | -0.20 53.49% | -0.38 | 0.18 | 47.01% |
| Q2 2020 Q2Q % growth | -0.23 61.02% | -0.38 | 0.15 | 39.06% |
| Q1 2020 Q2Q % growth | -0.30 62.50% | -0.34 | 0.04 | 10.87% |
| Q4 2019 Q2Q % growth | -0.34 | -0.35 | 0.01 | 1.96% |
| Q3 2019 Q2Q % growth | -0.43 | -0.71 | 0.28 | 39.78% |
| Q2 2019 Q2Q % growth | -0.59 | -0.82 | 0.23 | 27.70% |
| Q1 2019 Q2Q % growth | -0.80 | -1.12 | 0.32 | 28.70% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -100.00% | 793.56K | -793.56K | -100.00% |
| Q1 2025 Q2Q % growth | -100.00% | 1.826M | -1.826M | -100.00% |
| Q4 2024 Q2Q % growth | 11.131M -7.92% | 5.795M | 5.336M | 92.08% |
| Q3 2024 Q2Q % growth | 2.262M -63.43% | 3.64M | -1.378M | -37.86% |
| Q2 2024 Q2Q % growth | 3.971M 1.39% | 3.737M | 234.44K | 6.27% |
| Q1 2024 Q2Q % growth | 4.907M 64.33% | 9.894M | -4.987M | -50.41% |
| Q4 2023 Q2Q % growth | 12.088M 1,159.17% | 10.812M | 1.276M | 11.80% |
| Q3 2023 Q2Q % growth | 6.186M 289.04% | 3.228M | 2.958M | 91.63% |
| Q2 2023 Q2Q % growth | 3.917M | 1.53M | 2.387M | 156.01% |
| Q1 2023 Q2Q % growth | 2.986M | 510K | 2.476M | 485.49% |
| Q4 2022 Q2Q % growth | 960K | 5.1K | 954.9K | 18,723.53% |
| Q3 2022 Q2Q % growth | 1.59M | 214.2K | 1.376M | 642.30% |
| Q2 2022 Q2Q % growth | -100.00% | 397.8K | -397.8K | -100.00% |
| Q1 2022 Q2Q % growth | -100.00% | % | ||
| Q4 2021 Q2Q % growth | -100.00% | % | ||
| Q3 2021 Q2Q % growth | -100.00% | 214.2K | -214.2K | -100.00% |
| Q2 2021 Q2Q % growth | 200K 300.00% | 214.2K | -14.2K | -6.63% |
| Q1 2021 Q2Q % growth | 40K -78.95% | % | ||
| Q4 2020 Q2Q % growth | 60K -72.73% | 213.149K | -153.149K | -71.85% |
| Q3 2020 Q2Q % growth | 20K -85.71% | 213.149K | -193.149K | -90.62% |
| Q2 2020 Q2Q % growth | 50K -87.80% | 214.2K | -164.2K | -76.66% |
| Q1 2020 Q2Q % growth | 190K -17.39% | 214.2K | -24.2K | -11.30% |
| Q4 2019 Q2Q % growth | 220K | 35.7K | 184.3K | 516.25% |
| Q3 2019 Q2Q % growth | 140K | 204K | -64K | -31.37% |
| Q2 2019 Q2Q % growth | 410K | 224.4K | 185.6K | 82.71% |
| Q1 2019 Q2Q % growth | 230K | 438.6K | -208.6K | -47.56% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -17.88% | -47.97% | -125% | -347.18% |
| Revenue | -16.67% | -75.38% | -94.79% | -96.61% |